In sum, while in other tumor types, endogenous Sema3A levels are often suppressed and its reintroduction deploys inhibitory activity, autocrine Sema3A in GBM cells seems to act instead as promoter of migration via distinctive signaling cascades. The gene discussed is SEMA3A; the disease is glioblastoma.